Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sclerosing cholangitis.

E B Martins1, R W Chapman

  • 1Department of Clinical Medicine, Hospital Universitário, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil. emartins@writeme.com

Current Opinion in Gastroenterology
|October 7, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Case of Uterine Polypus Removed by the Ligature, in Which Dilatation of the Os Uteri Was Produced by the Administration of the Lobelia Inflata.

Edinburgh medical and surgical journal·2018
Same author

Editorial: vancomycin - a promising option for the treatment of primary sclerosing cholangitis?

Alimentary pharmacology & therapeutics·2018
Same author

Predictors of response to tenofovir disoproxil fumarate plus peginterferon alfa-2a combination therapy for chronic hepatitis B.

Alimentary pharmacology & therapeutics·2016
Same author

Early primary biliary cholangitis is characterised by brain abnormalities on cerebral magnetic resonance imaging.

Alimentary pharmacology & therapeutics·2016
Same author

A rare cause of colonic thickening and lymphadenopathy.

Gut·2016
Same author

Editorial: further evidence for the role of serum alkaline phosphatase as a useful surrogate marker of prognosis in PSC.

Alimentary pharmacology & therapeutics·2014
Same journal

Endoscopic techniques to minimize gastroesophageal reflux during peroral endoscopic myotomy.

Current opinion in gastroenterology·2026
Same journal

Postendoscopy esophageal adenocarcinoma and neoplasia: current status and future directions.

Current opinion in gastroenterology·2026
Same journal

The complement system in inflammatory bowel disease: from early observations to emerging frontiers.

Current opinion in gastroenterology·2026
Same journal

Goblet cell-associated antigen passages in health and disease.

Current opinion in gastroenterology·2026
Same journal

Inflammatory bowel diseases 2026: form, function and therapeutic considerations for the epithelial barrier.

Current opinion in gastroenterology·2026
Same journal

Dietary protein as a regulator of colitis and colorectal cancer.

Current opinion in gastroenterology·2026
See all related articles

Primary sclerosing cholangitis (PSC) is a serious liver disease with limited treatment options. Research is ongoing to identify PSC antigens and improve diagnostic and therapeutic strategies.

Area of Science:

  • Hepatology
  • Immunology
  • Genetics

Background:

  • Primary sclerosing cholangitis (PSC) is a chronic, progressive cholestatic liver disease leading to liver failure or cholangiocarcinoma.
  • Genetic associations include HLA A1-B8-DR3 haplotype, HLA C, and tumor necrosis factor genes.
  • Antineutrophil cytoplasmic antibodies are detected in PSC patients, with potential nuclear membrane antigens.

Purpose of the Study:

  • To summarize the current understanding of Primary Sclerosing Cholangitis (PSC).
  • To highlight genetic susceptibilities and immunological markers.
  • To review diagnostic methods and therapeutic outcomes.

Main Methods:

  • Review of existing literature on PSC.
  • Analysis of genetic association studies.

Related Experiment Videos

  • Evaluation of diagnostic imaging techniques.
  • Assessment of treatment modalities including transplantation.

    • Main Results:

    • PSC is linked to specific HLA haplotypes and TNF gene variations.
    • Antineutrophil cytoplasmic antibodies are present, but the specific antigen remains unidentified.
    • Magnetic resonance cholangiography offers a noninvasive diagnostic alternative to ERCP.
    • Liver transplantation is the only definitive treatment, though recurrence is possible.

    Conclusions:

    • PSC is a complex disease with significant genetic and immunological components.
    • Early diagnosis and management are crucial for patient outcomes.
    • Further research is needed to identify PSC antigens and develop effective medical therapies.
    • Liver transplantation offers a life-saving option, but potential complications and recurrence must be considered.